Technology transfer is a long-established part of early-stage research within the pharmaceutical and biotechnology industries. Although technology transfer offices have traditionally been associated with inefficiency and a lack of commercial judgment, recent trends have shown improvements in staffing, expertise and service levels. However, the tech transfer function has recently suffered from ‘funding gaps’ for promising new technologies. A clear disparity exists between current service offerings and demand levels amongst investors/industry partners, while the lack of an established model for effective technology transfer function and significant regional variations are major obstacles to future progress.
‘Technology Transfer Strategies’ is a new, uniquely themed report provides a comprehensive examination of the major trends in technology transfer activity in the US, Canada and Europe. The report provides a detailed country-level analysis of technology transfer and associated intellectual property technology regulations, in addition to evaluating the key approaches to office structuring and strategies to negotiate the ’funding gap’. A series of in-depth interviews also document the experiences and insights of 11 tech transfer experts, and their recommendations for successful technology transfer strategies are revealed.
To read the full, original article click on this link: Technology Transfer Strategies: Maximizing The Returns From New Technologies -Aarkstore Enterprise « Aarkstore.com
Author: aarkstore
